Westminster Group PLC (LON:WSG) said it has successfully conducted a trial of its fever screening solution at the Stockholm Arlanda airport in Sweden in association with Menzies Aviation and their client, Air France.
The company said Menzies will continue to use its solution to conduct operational trials with Air France and other clients’ flights over the coming weeks to “fine tune” the delivery of the screening.
Westminster noted that feedback from the first live trial was “extremely positive” with all passengers screened.
"Working with Menzies Aviation on the trial has been excellent. We have worked hard in order to supply them with the correct solution for their fever screening requirements that is fit for purpose and has the least impact on an already complex procedure, and within the required time frame. I need to thank all those involved at Menzies Aviation both in the UK and their team in Sweden for their efforts”, Westminster Group’s general manager, Hamish Russell said in a statement.
"Westminster's fever screening solutions have been supplied to numerous industry sectors to detect, mitigate and defeat the spread of [coronavirus]. Westminster continues to add to its fever screening offering ensuring products are adaptable, cost-effective and can be implemented and upgraded into existing processes or technology", he added.
Shares in the company jumped 6.4% higher to 11.2p in early trading on Wednesday.